CURE vs BLES
Comparison between DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF) and INSPIRE GLOBAL HOPE ETF (BLES, ETF).
5-Year PerformanceBLES has outperformed CURE, delivering a return of +7.1% compared to +2.3%
CURE vs BLES - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
CURE
$157M
BLES
$156M
Expense Ratio
CURE
N/A
BLES
0.60%
Max Drawdown
CURE
69.19%
Winner
BLES
40.35%
Sharpe Ratio
CURE
0.79
Winner
BLES
1.34
5Y Beta
CURE
1.38
Winner
BLES
0.77
P/E Ratio
Winner
CURE
28.04
BLES
29.25
Forward P/E
Winner
CURE
18.09
BLES
21.19
5Y Dividends CAGR
Winner
CURE
63.21%
BLES
6.58%
5Y EPS CAGR
CURE
12.58%
BLES
N/A
Debt to Equity
CURE
53.58%
Winner
BLES
18.54%
P/S Ratio
Winner
CURE
1.48
BLES
2.57
P/B Ratio
CURE
4.58
Winner
BLES
3.45
CURE vs BLES - Holdings Comparison
CURE and BLES have 11 common holdings. Overlap is -1.05%
CURE's top 25 holdings weight is 91.92%. BLES's top 25 holdings weight is 11.09%.
| Rank | CURE | BLES |
|---|---|---|
| #1 | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35% | CASH & CASH EQUIVALENTS (n/a) - 1.01% |
| #2 | ELI LILLY AND CO (LLY) - 11.75% | BLOOM ENERGY CORP CLASS A (BE) - 0.53% |
| #3 | DREYFUS GOVT CASH MAN INS (n/a) - 10.69% | MARVELL TECHNOLOGY INC (MRVL) - 0.52% |
| #4 | JOHNSON & JOHNSON (JNJ) - 7.72% | INFINEON TECHNOLOGIES AG (n/a) - 0.50% |
| #5 | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02% | SUPER MICRO COMPUTER INC (SMCI) - 0.49% |
| #6 | ABBVIE INC (ABBV) - 5.24% | ON SEMICONDUCTOR CORP (ON) - 0.49% |
| #7 | UNITEDHEALTH GROUP INC (UNH) - 4.75% | DATADOG INC CLASS A (DDOG) - 0.48% |
| #8 | MERCK & CO INC (MRK) - 4.14% | STMICROELECTRONICS NV (n/a) - 0.48% |
| #9 | AMGEN INC (AMGN) - 2.52% | SEMTECH CORP (SMTC) - 0.48% |
| #10 | THERMO FISHER SCIENTIFIC INC (TMO) - 2.34% | WESTERN DIGITAL CORP (WDC) - 0.47% |
| #11 | GILEAD SCIENCES INC (GILD) - 2.31% | RENESAS ELECTRONICS CORP (n/a) - 0.45% |
| #12 | INTUITIVE SURGICAL INC (ISRG) - 2.16% | QUALCOMM INC (QCOM) - 0.44% |
| #13 | ABBOTT LABORATORIES (ABT) - 2.10% | LATTICE SEMICONDUCTOR CORP (LSCC) - 0.39% |
| #14 | PFIZER INC (PFE) - 2.05% | FORTINET INC (FTNT) - 0.39% |
| #15 | BRISTOL-MYERS SQUIBB CO (BMY) - 1.65% | DEVON ENERGY CORP (DVN) - 0.38% |
| #16 | CVS HEALTH CORP (CVS) - 1.61% | NXP SEMICONDUCTORS NV (NXPI) - 0.38% |
| #17 | VERTEX PHARMACEUTICALS INC (VRTX) - 1.54% | SNOWFLAKE INC ORDINARY SHARES (SNOW) - 0.38% |
| #18 | DANAHER CORP (DHR) - 1.51% | FIRST SOLAR INC (FSLR) - 0.37% |
| #19 | STRYKER CORP (SYK) - 1.50% | SAMSUNG SDI CO LTD (n/a) - 0.36% |
| #20 | MEDTRONIC PLC (MDT) - 1.38% | COMMVAULT SYSTEMS INC (CVLT) - 0.36% |
| #21 | MCKESSON CORP (MCK) - 1.29% | CIENA CORP (CIEN) - 0.36% |
| #22 | BOSTON SCIENTIFIC CORP (BSX) - 1.19% | MONOLITHIC POWER SYSTEMS INC (MPWR) - 0.35% |
| #23 | ELEVANCE HEALTH INC (ELV) - 1.19% | MICROCHIP TECHNOLOGY INC (MCHP) - 0.35% |
| #24 | THE CIGNA GROUP (CI) - 1.03% | INTERTEK GROUP PLC (n/a) - 0.34% |
| #25 | REGENERON PHARMACEUTICALS INC (REGN) - 0.89% | NUCOR CORP (NUE) - 0.34% |
| Total Holdings | 65 | 418 |
CURE vs BLES - Historical Returns
Returns include dividend reinvestment.
1M
Winner
CURE
+22.71%
BLES
-0.20%
3M
CURE
-2.64%
Winner
BLES
+5.24%
6M
CURE
+3.17%
Winner
BLES
+11.64%
1Y
Winner
CURE
+35.83%
BLES
+20.72%
5Y(CAGR)
CURE
+2.35%
Winner
BLES
+7.14%
10Y(CAGR)
Winner
CURE
+13.12%
BLES
+10.02%
Max(CAGR)
Winner
CURE
+23.37%
BLES
+10.02%
CURE vs BLES - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | CURE | BLES |
|---|---|---|
| 2026 | -7.73% | +9.40% |
| 2025 | +22.87% | +18.98% |
| 2024 | -12.90% | +6.64% |
| 2023 | -8.46% | +16.81% |
| 2022 | -17.91% | -15.92% |
| 2021 | +90.55% | +25.04% |
| 2020 | +4.13% | +11.97% |
| 2019 | +62.36% | +28.27% |
| 2018 | -0.75% | -14.67% |
| 2017 | +62.77% | +15.22% |
| 2016 | -12.42% | N/A |
| 2015 | +6.24% | N/A |
| 2014 | +83.03% | N/A |
| 2013 | +153.15% | N/A |
| 2012 | +45.79% | N/A |
| 2011 | -9.68% | N/A |
CURE vs BLES Drawdown Comparison
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The maximum drawdown for BLES was -40.35%, occurring on Mar 23, 2020. Recovery took 205 trading sessions.
The current CURE drawdown is -25.85%. The current BLES drawdown is -2.01%.
| Rank | CURE | BLES |
|---|---|---|
| #1 | -69.19% Jan 22, 2020 - Jan 6, 2021 | -40.35% Jan 17, 2020 - Nov 9, 2020 |
| #2 | -52.25% Apr 8, 2022 - Aug 7, 2025 | -26.62% Jan 4, 2022 - Mar 4, 2024 |
| #3 | -48.54% Jul 20, 2015 - Jun 22, 2017 | -21.82% Jan 26, 2018 - Nov 4, 2019 |
| #4 | -44.44% Jul 1, 2011 - Mar 15, 2012 | -15.46% Sep 27, 2024 - May 13, 2025 |
| #5 | -42.27% Oct 1, 2018 - Nov 27, 2019 | -8.29% Feb 11, 2026 - Apr 17, 2026 |
| #6 | -36.35% Jan 26, 2018 - Sep 13, 2018 | -5.90% Nov 16, 2021 - Dec 27, 2021 |
| #7 | -29.28% Dec 30, 2021 - Apr 8, 2022 | -5.74% Jun 8, 2021 - Aug 27, 2021 |
| #8 | -22.89% Aug 17, 2021 - Dec 15, 2021 | -5.57% Jul 16, 2024 - Aug 19, 2024 |
| #9 | -22.59% Sep 24, 2014 - Oct 28, 2014 | -5.42% Mar 28, 2024 - May 14, 2024 |
| #10 | -19.78% Mar 4, 2014 - Jun 19, 2014 | -5.03% Jan 20, 2021 - Feb 11, 2021 |
| #11 | -19.31% Oct 17, 2012 - Jan 9, 2013 | -4.87% Oct 27, 2025 - Dec 10, 2025 |
| #12 | -19.31% Jan 20, 2021 - Apr 15, 2021 | -4.79% Sep 3, 2021 - Oct 22, 2021 |
| #13 | -17.38% Apr 2, 2012 - Jun 29, 2012 | -4.71% Aug 30, 2024 - Sep 19, 2024 |
| #14 | -15.49% May 28, 2013 - Jul 12, 2013 | -3.91% May 17, 2024 - Jul 12, 2024 |
| #15 | -14.96% Dec 8, 2014 - Jan 22, 2015 | -3.62% Jul 23, 2025 - Aug 22, 2025 |
Correlation
Correlation between CURE and BLES is 0.79 which considered as a strong positive correlation - the stocks tend to move together.
0.79
-101
Dividend Comparison (2011 - 2026)
CURE vs BLES dividend yield comparison.
| Year | CURE | BLES |
|---|---|---|
| 2026 | 0.27% | 0.19% |
| 2025 | 1.12% | 1.97% |
| 2024 | 1.17% | 1.90% |
| 2023 | 2.02% | 1.80% |
| 2022 | 0.38% | 1.64% |
| 2021 | 0.02% | 9.28% |
| 2020 | 0.17% | 1.61% |
| 2019 | 0.40% | 2.16% |
| 2018 | 0.70% | 1.73% |
| 2017 | 0.18% | 2.01% |
| 2013 | 1.24% | 0.00% |
| 2012 | 0.03% | 0.00% |
| 2011 | 2.10% | 0.00% |
Select Stocks to Compare
Popular: CURE vs SPYBLES vs SPY
More Comparisons
Compare with similar stocks